Lucence Company
Lucence is a company that produces Liquid Biopsy Tests for cancer detection and treatment. These tests are ultrasensitive and non-invasive, requiring only a single draw of blood.
%20.jpg)
%20.jpg)
Funding Status:
Early Stage Venture
Investors Number:
5
Estimated Revenue:
$10M to $50M
Total Funding:
$29.2M
Industry:
Biotechnology, Genetics, Health Care, Health Diagnostics, Medical
Employee Number:
11-50
Last Funding Date:
2019-11-20
Headquarters:
Singapore
Founded Date:
42461
Last Funding Type:
Series A
Technology:
diagnostics
Investor Type:
For Profit